Imatinib-induced hyperpigmentation
Garraway, Caroline +4 more
openaire +2 more sources
A Rare Clinical Pattern: Acquired Dermal Melanocytosis of Nose. [PDF]
Demir BM, Öztürk F, Sarıcaoğlu H.
europepmc +1 more source
Pattern of Facial Dyschromias: A Clinical and Dermoscopic Study from a Tertiary Healthcare Center in South India. [PDF]
Kotekar S, Thappa DM, Munisamy M.
europepmc +1 more source
Facial Melanosis in Skin of Color: An Integrated Clinical, Dermoscopic, and Quality of Life Analysis. [PDF]
Goswami A +4 more
europepmc +1 more source
Severe Hyperpigmentation in the Emergency Department. [PDF]
van Veggel KM +2 more
europepmc +1 more source
Use of Castor Oil in Dermatology: A Narrative Review. [PDF]
Girdler K, Cabatu A, Olds H, Potts GA.
europepmc +1 more source
Interventions to Prevent Postinflammatory Hyperpigmentation After Laser and Energy-Based Device Treatments: A Systematic Review and Network Meta-Analysis. [PDF]
Wongdama S +5 more
europepmc +1 more source
Comparing the Efficiency of Microneedling and Tranexamic Acid Versus Microneedling and Vitamin C in the Treatment of Infraorbital Hyperpigmentation. [PDF]
Pazyar N +3 more
europepmc +1 more source
Related searches:
Postinflammatory Hyperpigmentation
Journal of Cutaneous Medicine and Surgery, 2009Background: Postinflammatory hyperpigmentation (PIH) commonly occurs in Fitzpatrick skin types III to VI and can have a considerable impact on quality of life. The majority of cases will improve spontaneously, but this can take months or even years to resolve and in some cases can be permanent.
Susan, Taylor +4 more
openaire +2 more sources

